Search

Author/Creator Archer, David F

4. Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials. Issue 8 (August 2019)

Authors:
Archer, David F; Merkatz, Ruth B; Bahamondes, Luis; Westhoff, Carolyn L; Darney, Philip; Apter, Dan; Jensen, Jeffrey T; Brache, Vivian; Nelson, Anita L; Banks, Erika; Bártfai, György; Portman, David J; Plagianos, Marlena; Dart, Clint; Kumar, Narender; Creasy, George W; Sitruk-Ware, Regine; Blithe...
Journal:
Lancet
Issue:
Volume 7:Issue 8(2019)
Page Start:
e1054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain. Issue 4 (December 2019)

Authors:
Leyland, Nicholas; Taylor, Hugh S; Archer, David F; Peloso, Paul M; Soliman, Ahmed M; Palac, Hannah L; Martinez, Marisol; Abrao, Mauricio S
Journal:
Journal of endometriosis and pelvic pain disorders
Issue:
Volume 11:Issue 4(2019)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗